Posts falsely claim Pfizer published list of Covid-19 vaccine side effects
Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...
C&EN4d
Pfizer readies its next-generation COVID-19 antiviral
An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...
Pfizer appoints former J&J executive to lead obesity drug development
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
The Pharma Letter3d
Pfizer lures former J&J exec to be its CIMO
US pharma giant Pfizer (NYSE: PFE) today announced that James List, has joined the company as chief internal medicine officer ...
Fierce Biotech6d
Pfizer adds J&J, BMS vet James List to its executive roster as new chief internal medicine officer
Shortly after bringing in a former FDA official to serve as its chief medical officer, Pfizer’s latest leadership appointment ...
Pfizer: Undervalued Safe Haven In Risk-Off Market
Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...
Pfizer boosts anti-obesity efforts: adds former J&J exec. as chief internal medicine officer
Pfizer (NYSE:PFE) has named James List, a former Johnson & Johnson (NYSE:JNJ) executive, as the company’s new chief internal ...
Pfizer names James List Chief Internal Medicine Officer
Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine ...
pharmaphorum4d
Pfizer eyes AI-powered drug discovery and development software
Charlotte Allerton, Pfizer's head of medicine design, said: "The XtalPi collaboration is an opportunity to enhance our computational modelling capabilities. "We are looking forward to potentially ...
Pfizer appoints former J&J executive to lead development of obesity medicines
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
Seeking Alpha6d
Pfizer boosts anti-obesity efforts: adds former J&J exec. as chief internal medicine officer
Pfizer (NYSE:PFE) has named James List, a former Johnson & Johnson (NYSE:JNJ) executive, as the company’s new chief internal medicine officer to boost the company's efforts in obesity drug ...